Эпидемиология хронической воспалительной демиелинизирующей полиневропатии за рубежом и в России

Представлен обзор результатов эпидемиологических исследований хронической воспалительной демиелинизирующей полиневропатии (ХВДП) в России и за рубежом. Показано, что распространенность ХВДП различается в разных странах, что обусловлено использованием разных критериев диагностики. Следует заметить, что на получении достоверности эпидемиологических показателей сказываются трудности диагностики атипичных форм заболевания.

1. Tackenberg B., Lunemann J.D., Steinbrecher A. et al. Classifications and treatment responses in immune-mediated demyelinating polyneuropathy. Neurology 2007;68:1622-9.

2. Подчуварова Е.В. Достижения в диагностике и лечении хронической воспалительной демиелинизирующей полиневропатии и других иммунологически опосредованных невропатий. Неврол журн 2003;(4):59-64. [Podchuvarova E.V. Advances in diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy and other immunologically-mediated neuropathies. Nevrologicheskiy zhurnal = Nevrol J 2003;(4):59-64. (In Russ.)].

3. Baig F., Knopp M., Rajabally Y.A. Diagnosis, epidemiology and treatment of inflammatory neuropathies. Br J Hosp Med 2012;73:380-5.

4. Boukhris S., Magy L., Gallouedec G. et al. Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases. J Peripher Nerv Syst 2005;10(3):329-37.

5. Dalakas M.C. Medscape. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 2011;7: 507-17.

6. Dalakas M.C. Clinical trials in CIDP and chronic autoimmune inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2012;7(Suppl):34-9.

7. Koller H., Кieseier B., Jandar S., Hartung H.-P. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005;352:1343-56.

8. Pollard J., Аrmati P. CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology. J Peripher Nerv Syst 2011;16(1):15-23.

9. Saperstein D.S., Katz J.S., Amato A.A., Barohn R.J. Сlinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311-24.

10. Vedeler C.A., Farbu E., Mellgren S.I. Chronic inflammatory demyelinating polyneuropathy (CIDP). Acta Neurol Scand 2013;127(Suppl 196):48-51.

11. Chin R.L., Latov N., Sander H.W. Sensory CIDP presenting as cryptogenic sensory polyneuropathy. J Peripher Nerv Syst 2004;9:132-7.

12. Mygland Е. Kronisk polynevropati - Utredning og diagnostikk. Tidsskr den Nor Laegeforening 2007;127(3):291-5.

13. Супонева Н.А, Никитин С.С., Пирадов М.А., Меркулова Д.М. Хроническая воспалительная демиелинизирующая полиневропатия с острым началом и дыхательной недостаточностью. Нервные болезни 2007;(1):40-4. [Suponeva N.A., Nikitin S.S., Piradov M.A., Merkulova D.M. Chronic inflammatory demyelinating polyneuropathy with acute onset and respiratory failure. Nervnye bolezni = Nervous Diseases 2007;(1):40-4. (In Russ.)].

14. Супонева Н.А. Клиническая и диагностическая роль аутоантител к ганглиозидам периферических нервов: обзор литературы и собственные данные. Нервно-мышечные болезни 2013;(1):26-33. [Suponeva N.A. Clinical and diagnostic role of autoantibodies to gangliosides of peripheral nerves: review of the literature and our own data. Nervnomyshechnye bolezni = Neuromuscular Diseases 2013;(1):26-33. (In Russ.)].

15. Kerasnoudis A. The role of neuromuscular ultrasound when diagnosing chronic inflammatory demyelinating polyneuropathy. US Neurol 2013;9(1):52-4.

16. Magda P., Latov N., Brannagan T.H. III. et al. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 2003;60:1755-9.

17. Rabin M., Mutlu G., Stojkovic T. et al. Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal. J Neurol Neurosurg Psychiatry 2013;85(8):901-6.

18. Rajabally Y.A., Nicolas G., Piйret F. et al. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009;80:1364-8.

19. Schneider-Hohendorf T., Schwab N., Uзeyler N. et al. CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2012;78(6):402-8.

20. Vanasse M., Rossignol E., Hadad E. Chronic inflammatory demyelinating polyneuropathy. Handb Clin Neurol 2013;112:1163-9.

21. Кантимирова Е.А., Шнайдер Н.А. Хроническая воспалительная демиелинизирующая полинейропатия: дефиниция, эпидемиология, классификация, диагностика. Вестник клинической больницы № 51. 2009;(7):22-25. [Kantimirova E.A., Shnayder N.A. Chronic inflammatory demyelinizing polyneuropathy: definition, epidemiology, classification, diagnosis. Bulletin of the Hospital № 51. 2009;(7):22-25. (In Russ.)].

22. Шнайдер Н.А., Кантимирова Е.А. Эпидемиологическая и клиническая характеристика отдельных форм полиневропатий (на примере ЗАТО Железногорск Красноярского края). Нервно-мышечные болезни 2011;(1):34-40. [Shnayder N.A., Kantimirova E.A. Epidemiologial and clinical characteristics of some forms of polyneuropathies (on example CATE Zheleznogоrsk of Krasnoyarsk region). Nervno-myshechnye bolezni = Neuromuscular Diseases 2011;(1):34-40. (In Russ.)].

23. Lünemann J.D., Tackenberg B., Stein A. et al. Dysregulated Epstein-Barr virus infection in patients with CIDP. J Neuroimmunol 2010;218(1-2):107-11.

24. Thornton C.A., Latif A.S., Emmanuel J.C. Guillain-Barrѐ syndrome associated with human immunodeficiency virus infection in Zimbabwe. J Neurol 1991;41(6):812-5.

25. Bhigjee A.I. Neurological manifestations of HIV infection in Kwazulu-Natal South Africa. J Neurovirol 2005;11(Suppl 1):17-21.

26. Barohn R.J., Kissel J.T., Warmolts J.R., Mendell J.R. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-84.

27. Hughes R.A., Bouche P., Cornblath D.R. et al. European Federation of Neurological Societies/Peripheral Nerve Society guidelines on management of chronic inflammatory demyelinating polyneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-32.

28. Lewis R., Jeremy M.S. Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis. Neurophysiol Clin 2004;34(2):71-9.

29. Molenaar D.S., Vermeulen M., de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64:84-9.

30. Rajabally Y.A., Chavada G. Lewis-sumner syndrome of pure upper-limb onset: diagnostic, prognostic, and therapeutic features. Muscle Nerve 2009;39:206-20.

31. Santos P., Almeida-Ribeiro G., Silva D. et al. Chronic inflammatory demyelinating polyneuropathy: quality of life, sociodemographic profile and physical complaints. J Arquivos de Neuro-Psiquiatria 2014;72(3):179-83.

32. Vallat J.M., Tabaraud F., Magy L. et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve 2003;27:478-85.

33. McLeod J.G., Pollard J.D., Macaskill P. et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999;46: 910-3.

34. Majumdar A., Hartley L., Manzur A.Y. et al. A case of severe congenital chronic inflammatory demyelinating polyneuropathy with complete spontaneous remission. Neuromuscul Disord 2004;14(12):818-21.

35. Куренков А.Л., Никитин С.С., Бурсагова Б.И., Кузенкова Л.М. Особенности хронической воспалительной демиелинизирующей полинейропатии у детей. Нервно-мышечные болезни 2012;(2): 40-51. [Kurenkov A.L., Nikitin S.S., Bursagova B.I., Kuzenkova L.M. Features of chronic inflammatory demyelinating polyneuropathy in children. Nervnomyshechnye bolezni = Neuromuscular Diseases 2012;(2):40-51. (In Russ.)].

36. Pearce J., Pitt M., Martinez A. A neonatal diagnosis of congenital chronic inflammatory demyelinating polyneuropathy. Devel Med Child Neurology 2005;47(7):489-92.

37. Шнайдер Н.А., Кантимирова Е.А., Глущенко Е.В., Козулина Е.А. Эпидемиология периферической нейропатии в России и за рубежом. Вестник НГУ. Серия: Биология и клиническая медицина 2009;7(3):139-42. [Shnayder N.A., Kantimirova E.A., Gluschenko E.V., Kozulina E.A. Epidemiology of peripheral neuropathy in Russia and abroad. Vestnik NSU. Series: Biology and Clinical Medicine. 2009;7(3):139-42. (In Russ.)].

38. Chiт A., Cocito D., Bottacchi E. et al. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. J Neurol Neurosurg Psychiatry 2007;78:1349-53.

39. Iijima M., Koike H., Hattori N. et al. Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. J Neurol Neurosurg Psychiatry 2008;79(9):1040-3.

40. Laughlin R., Dyck P., Melton L. et al. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 2009;73:39-45.

41. Lunn M.P., Manji H., Choudhary P.P. et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999;66:677-80.

42. Mygland A., Monstad P. Chronic polyneuropathy in Vest-Agder, Norway. Eur J Neurol 2001;8(2):157-65.

43. Taylor T. Chronic inflammatory demyelinating polyradiculoneuropathy: in a remote northern Ontario hospital. Can Fam Physician 2013;59:368-71.

44. Thaisetthawatkul P., Logigian E.L., Herrmann R.A., Thomas P.K. Chronic inflammatory demyelinating polyneuropathy: a prevalence study in South-East England. J Neurol Neurosurg Psychiatry 1999;66: 677-80.

45. Rajabally Y.A., Simpson B.S., Beri S. et al. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population. Muscle Nerve 2009;39(4):432-8.

46. Mahdi-Rogers M., Hughes R.A.C. Epidemiology of chronic inflammatory neuropathies in southeast England. Eur J Neurol 2014;21(1):28-33.

47. Hartung H.P., Lehmann H.C., Willson H.G. Peripheral neuropaties: establishing common clinical research standarts for CIDP. Nat Rev Neurol 2011; 16(Suppl):63-7.

48. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Taskforce. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-8.

49. Albers J.W., Kelly J.J. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989;12:435-51.

50. Kandil M.R., Darwish E.S., Khedr E.M. et al. A community-based epidemiological study of peripheral neuropathies in Assiut, Egypt Neurol Res 2012;34(10):960-6.

51. Koul R., Chacko A., Javed H. et al. A profile of childhood neuropathies at a university hospital in Oman. Saudi Med J 2002;23(4):450-6.

52. Lin K.P., Kwan S.Y., Chen S.Y. et al. Generalized neuropathy in Taiwan: an etiologic survey. J Neuroepidemiol 1993;12(5):257-61.

53. Ghosh B., Sengupta S., Bhattacharjee R. et al. Spectrum of peripheral neuropathy in eastern India. J Indian Med Assoc 2006;104(4):168-73.

54. Kusumi M., Nakashima K., Nakayama H., Takahashi K. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan. Psychiatry Clin Neurosci 1995;49(3):169-74.

55. San-Juan O.D., Castro-Macнas J.I. Chronic inflammatory demyelinating polyradiculoneuropathy. 10 years' experience in a Mexican centre. Rev Neurol 2008;46(11):656-9.

56. Storey E., Cook M., Peppard R. et al. Guillain-Barrй syndrome and related conditions in Victorian teaching hospitals 1980-84. Aust NZJ Med 1989;19(6):687-93.

57. Никитин С.С., Супонева Н.А., Пирадов М.А. и др. Синдром Гийена-Баре и хроническая воспалительная демиелинизирующая полиневропатия с острым началом: проблемы дифференциальной диагностики. Клиническая неврология 2009;(2):30-5. [Nikitin S.S., Suponeva N.A., Piradov M.A. et al. Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy with acute onset: problem of differential diagnosis. Clinicheskaya nevrologia = J Clin Neurol 2009;(2):30-5. (In Russ.)].